Win Thiri Kyaw

Dr. Win Thiri Kyaw

Research Institute for Humanity and Nature
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Pyae Sone SoePyae Sone Soe
Pyae Sone Soe
Win Thiri KyawWin Thiri Kyaw
Win Thiri Kyaw
Koji ArizonoKoji Arizono
Koji Arizono
YIYasuhiro Ishibashi
Yasuhiro Ishibashi
TATetsuro Agusa
Tetsuro Agusa
Mercury (Hg) is one of the most harmful metals and has been a public health concern according to the World Health Organization (WHO). Artisanal and small-scale gold mining (ASGM) is the world’s fastest-growing source of Hg and can release Hg into the atmosphere, hydrosphere, and geosphere. Hg has been widely used in ASGM industries throughout Southeast Asia countries, including Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, and Thailand. Here, 16 relevant studies were systematically searched by performing the PRISMA flow, combining the keywords of “Hg”, “ASGM”, and relevant study areas. Mercury concentrations exceeding the WHO and United States Environmental Protection Agency guideline values were reported in environmental (i.e., air, water, and soil) and biomonitoring samples (i.e., plants, fish, and human hair). ASGM-related health risks to miners and nonminers, specifically in Indonesia, the Philippines, and Myanmar, were also assessed. The findings indicated severe Hg contamination around the ASGM process, specifically the gold-amalgamation stage, was significantly high. To one point, Hg atmospheric concentrations from all observed studies was shown to be extremely high in the vicinity of gold operating areas. Attentions should be given regarding the public health concern, specifically for the vulnerable groups such as adults, pregnant women, and children who live near the ASGM activity. This review summarizes the effects of Hg in Myanmar and other Southeast Asian countries. In the future, more research and assessment will be required to investigate the current and evolving situation in ASGM communities.

1 April 2011 in Brain Research
Verified
Journal Article
Closed access
MCMohammed Emamussalehin Choudhury
Mohammed Emamussalehin Choudhury
TMTakashi Moritoyo
Takashi Moritoyo
MKMadoka Kubo
Madoka Kubo
Win Thiri KyawWin Thiri Kyaw
Win Thiri Kyaw
HYHayato Yabe
Hayato Yabe
MNMasahiro Nomoto
Masahiro Nomoto

1 August 2012 in European Journal of Pharmacology
Verified
Journal Article
Closed access
MCMe Choudhury
Me Choudhury
KSK Sugimoto
K Sugimoto
MKM Kubo
M Kubo
HIH Iwaki
H Iwaki
TTT Tsujii
T Tsujii
MNM Nomoto
M Nomoto

1 April 2018 in Journal of Pharmacological Sciences
Verified
Journal Article
Open access
RARina Ando
Rina Ando
MCMohammed Emamussalehin Choudhury
Mohammed Emamussalehin Choudhury
YYYuki Yamanishi
Yuki Yamanishi
Win Thiri KyawWin Thiri Kyaw
Win Thiri Kyaw
MKMadoka Kubo
Madoka Kubo
MNMasahiro Nagai
Masahiro Nagai
Treatment with dopaminergic agents result excessive daytime sleepiness (EDS) and some studies have shown the benefit of using modafinil for treating excessive daytime sleepiness of Parkinson's disease (PD) patient. We investigated whether modafinil have ameliorative properties against levodopa induced excessive nighttime sleepiness (ENS) in MPTP-treated murine nocturnal PD model. Our EEG analyses of whole day recordings revealed that modafinil reduce ENS of this nocturnal PD models with levodopa medications. Therefore, we investigated whether, modafinil post-treatment followed by MPTP shows any effect on monoamine contents of brain and found to robustly increased noradrenaline (NA) concentration of MPTP treated mice. Modafinil post-treatment, in neurorestorative context (5 days post-lesion) led to increased striatal dopamine (DA) concentrations of MPTP-treated mice. Here, we first confirmed that modafinil ameliorates levodopa induced excessive sleepiness and restores monoaminergic systems. The arousal and anti-parkinsonian effects displayed by modafinil indicate that in combination with dopaminergic agents, modafinil co-administration may be worthwhile in trying to suppress the excessive daytime sleepiness and progressive dopaminergic neuron loss in PD.

1 March 2013 in Clinical Neuropharmacology
Verified
Journal Article
Closed access
Win Thiri KyawWin Thiri Kyaw
Win Thiri Kyaw
MNMasahiro Nagai
Masahiro Nagai
MKMika Kaneta
Mika Kaneta
MKMadoka Kubo
Madoka Kubo
NNNoriko Nishikawa
Noriko Nishikawa
MNMasahiro Nomoto
Masahiro Nomoto
Some patients with Parkinson disease improved their symptoms on treatment with nicotine patch or gum. Nicotine has also been studied for its antidyskinetic effect on levodopa-induced dyskinesia. We determined the effects of nicotine on levodopa pharmacokinetics and gastric emptying in healthy subjects and on levodopa transport in Caco-2 monolayers in vitro. Healthy subjects received transdermal nicotine patch application followed by oral levodopa/benserazide, 100/25 mg, in a fasting state and with enteral nutrition. Levodopa pharmacokinetics was determined, and gastric emptying was evaluated by carbon 13 ((13)C)-labeled acetic acid breath testing. In vitro studies using intestinal Caco-2 cell monolayers evaluated whether the intestinal transport of levodopa was affected by nicotine and its metabolite, cotinine. Nicotine did not increase mean plasma concentration significantly during fasting or with enteral nutrition, although the extent of levodopa absorption was reduced by 34% to 60% in some individuals and the mean plasma concentration of levodopa was statistically decreased by nicotine in subjects who received enteral nutrition. However, gastric parameters were not significantly affected by nicotine. Nicotine and cotinine at 0.1 μmol/L significantly reduced levodopa uptake by Caco-2 cells (P < 0.01). We found that nicotine reduced plasma levodopa concentration in some healthy subjects but with no alteration of gastric emptying rate. In vitro, nicotine inhibited levodopa transport by Caco-2 cell monolayers in an α-methyl amino isobutyric acid-independent, 2-amino-norbornanecarboxylic acid-dependent manner. These results suggest that nicotine may inhibit the transport of levodopa by the system L-amino acid transporter.

Win Thiri KyawWin Thiri Kyaw
Win Thiri Kyaw
暁匡暁旭 匡
暁旭 匡
Masayuki SakakibaraMasayuki Sakakibara
Masayuki Sakakibara
Increasing artisanal and small-scale gold mining (ASGM) in developing countries has raised health concerns in mining communities. A preliminary health survey was conducted in Thabeikkyin Township, Mandalay Region, Myanmar, in February 2020 to assess the health conditions of an ASGM community. Respiratory function and other clinical assessments were evaluated in miners and non-miners, and participants’ hair was analyzed for heavy metals. Respiratory function of miners was similar to that of non-miners. However, miners’ respiratory function declined with longer mining activity duration. In total, 3 out of 18 miners showed neurological signs and symptoms of chronic mercury intoxication. The median concentration of the hair mercury was significantly higher in miners than non-miners (P = 0.01), and 9 out of 18 miners and 2 out of 11 non-miners showed the warning level of mercury. We found that, despite an association between declining respiratory function and length of time mining, only a minority of miners showed clinical features of chronic mercury intoxication. Further clinical surveys with a larger sample size are necessary to determine the broader health status of this community. In addition, clinical indicators such as pulmonary function tests are recommended as additional criteria for the diagnosis of mercury intoxication.